Status:
COMPLETED
Emotional Awareness and Expression Therapy for Prediabetes
Lead Sponsor:
Wayne State University
Conditions:
PreDiabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This feasibility study seeks to develop and pilot test Emotional Awareness and Expression Therapy as a possible treatment for people with prediabetes.
Detailed Description
Prediabetes is a clinical condition in which hemoglobin A1C is between 5.6 and 6.4, and is usually associated with being overweight, poor diet, limited exercise, and psychological stress. This conditi...
Eligibility Criteria
Inclusion
- Affiliated with Wayne State University (faculty, staff, student, or family member/friend thereof)
- HbA1C value of 5.7% to 6.4%
- overweight or obese (≥25 kg/m2) Also, if over ≥ 18 and \< 45 years of age must have at least one of the following: a) physical inactivity, b) close family history of diabetes, c) history of hyperlipidemia, d) history of hypertension, e) history of gestational diabetes, and/or f) from high risk race groups (e.g., African American, Latino, Native American, and pacific Islander).
Exclusion
- Confirmed history of Type 2 Diabetes
- have prediabetes being treated pharmacologically
- pregnant
- taking medications that affect blood glucose (e.g., corticosteroids)
- chronic depression or major psychotic disorder
- any comorbidities that limit survival or ability to tolerate the intervention (Cushing's, cancer treatment, asthma with inhaled corticosteroids, unstable CAD or MI in last 6 months, CHF, COPD requiring oxygen, chronic kidney disease)
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2022
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05344196
Start Date
March 1 2022
End Date
December 15 2022
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wayne State University
Detroit, Michigan, United States, 48202